Loading...
Market
Next major lawsuit target in opioid crisis by June 30, 2025
2
Resolution / Starting Odds
Johnson & Johnson • 25%
Teva Pharmaceuticals • 25%
Purdue Pharma • 25%
Other • 25%
Legal filings and news reports
Story
McKesson and AmerisourceBergen to Pay $260M for Role in Baltimore's Opioid Crisis, Jury Rules Tuesday
Nov 12, 2024, 07:17 PM
A jury has found two drug distributors, McKesson and AmerisourceBergen, liable for contributing to Baltimore’s opioid crisis. The companies have been ordered to pay more than $260 million in damages. Baltimore alleged that the drug distributors fueled the city’s opioid epidemic by sending hundreds of millions of addictive painkillers to the area with little regard for the havoc they could wreak. This ruling is part of a broader national effort to hold companies accountable for their roles in the opioid crisis. The jury's decision was made on Tuesday.
View original story
Similar markets
Johnson & Johnson • 25%
Teva Pharmaceuticals • 25%
Endo International • 25%
Other • 25%
New lawsuit against another consulting firm • 25%
New lawsuit against pharmaceutical company • 25%
Introduction of new regulations • 25%
No major action • 25%
Settlement • 25%
Trial verdict • 25%
Dismissal • 25%
Other • 25%
McKesson • 25%
Cardinal Health • 25%
AmerisourceBergen • 25%
Other • 25%
U.S. Department of Justice • 25%
Federal Trade Commission • 25%
Securities and Exchange Commission • 25%
Other • 25%
McKinsey & Company • 25%
Bain & Company • 25%
Boston Consulting Group • 25%
Other • 25%
California • 25%
New York • 25%
Texas • 25%
Other • 25%
Walgreens • 25%
Rite Aid • 25%
Walmart • 25%
None of the above • 25%
